In this video, health care analysts David Williamson and Max Macaluso discuss Dendreon's upcoming third-quarter earnings. David highlights what investors need to look for in the company's press release -- and more importantly, the conference call. Watch and be prepared for Friday's big news.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 10/28/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
- BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
- Edwards Lifesciences Corporation (EW) Q3 2021 Earnings Call Transcript
- GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript
- Why Teva Pharmaceutical Industries Fell Today
- Why Nurix Therapeutics Stock Soared More Than 21% Wednesday